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Tropical pulmonary eosinophilia (TPE), a disease originally 
described in India in 1940 (l), is one of the many PIE 
(pulmonary infiltrates with peripheral blood eosinophilia) 
syndromes. TPE is an interstitial lung disease thought to 
result from immunological hyper-responsiveness to the 
human lymphatic-dwelling filarial parasites Wuchereria 
bancrofti and Bvugia malayi, although other non-filarial 
helminth-induced PIE syndromes resembling TPE have 
been described recently (2). TPE is characterized by parox- 
ysmal bouts of cough and wheezing, pulmonary infiltrates; 
with laboratory studies demonstrating extreme peripheral 
eosinophilia (>2500 cells per ~1) and high serum levels of 
total, as well as filaria-specific, IgE and IgG antibodies (3). 
TPE is especially prominent in India and South-east Asia, 
although isolated cases have been reported from endemic 
areas elsewhere. The prevalence of TPE in the U.K. is 
unclear. Case reports in the literature are sporadic and 
probably underplay its true incidence, especially as this 
disease may go unrecognized or be misdiagnosed (4). With 
a doubling in the number of travellers returning from all 
endemic areas in the past 5 years (5) and a lo-fold increase 
in immigration rates since 1987 (6), it is inevitable that the 
disease burden will rise. 
Of the approximately 90 million people infected world- 
wide with these parasitic filarial nematodes, less than 1% 
manifest with symptoms of TPE (7). However, it is not clear 
what determines that unusual response to filarial infection. 
TPE can readily be distinguished from other PIE syn- 
dromes by the patient’s history of residence in the tropics, 
by the presence of extraordinarily high levels of both serum 
IgE and antifilarial antibodies, and by the dramatic thera- 
peutic response to the filaricide diethylcarbamazine (DEC). 
Patients’ symptoms may masquerade as asthma for many 
years; it is essential, therefore, to take a detailed travel 
history from patients with suspected disease so that correct 
treatment may be offered early. 
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The pathogenesis of this illness is thought to arise from 
intense inflammation in the lung parenchyma to trapped 
microfilariae, which are released into the circulation by 
adult worms residing in the lymphatic system. As TPE 
occurs only in those individuals who are highly sensitized to 
filarial antigens, it is proposed that this represents an 
immunopathological response rather than as a result of 
direct damage by microfilariae. Although these micro- 
filariae are always absent from the peripheral blood, they 
may sometimes be seen at lung biopsy (8), where their 
presence suggests an intense local inflammatory and 
immune response resulting from their degeneration and 
release of antigenic components and the subsequent mas- 
sive recruitment of eosinophils. The exact processes that 
mediate the pulmonary abnormalities of TPE are poorly 
understood, but some progress has recently been made into 
the characterization of the components of the local humoral 
immune response in the lung. Bronchoalveolar lavage of 
affected individuals reveals that polyclonal IgE, and filarial- 
specific IgM, IgG and IgE, accumulate in the lung at high 
levels, together with a striking eosinophilic alveolitis. These 
changes return to normal rapidly after treatment, reflecting 
the clinical response (9). The recent identification and 
characterization of a major IgE-inducing filarial antigen of 
B. maluyi which is prominently expressed in microfilariae 
and not in the adult worm (10); suggests that there might be 
a degree of compartmentalization of the antibody response 
at the site where pathology is occurring, clearing micro- 
filariae in their first pass through the lung. High serum 
levels of IgE antibodies are a characteristic finding in TPE 
suggesting profound dysregulation in the otherwise tightly 
regulated IgE antibody response. 
The radiological findings are variable. The chest film can 
be normal, but generally shows increased bronchovascular 
markings, diffuse nodules l-3 mm in size, or diffuse, 
mottled opacities involving the middle and lower regions of 
the chest. A number of studies have addressed the spiro- 
metric abnormalities in TPE (11,12), usually revealing a 
combination of obstructive and restrictive ventilatory 
impairment, with a significant reduction in the carbon 
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monoxide transfer factor. Of interest, significant improve- 
ment in almost all indices of lung function (including 
arterial gases) occurs, even within the first month of treat- 
ment. However the transfer factor and forced expiratory 
volume may remain significantly impaired for 2 or more 
years, which suggests that a degree of irreversible interstitial 
fibrosis also accompanies the acute changes. Lung biopsies 
from patients with persistent spirometric impairment have 
corroborated this hypothesis (13). A persistent low-grade 
alveolitis is likely to be the cause of this progressive 
pulmonary fibrosis. Further study is necessary to elicit 
the cause of this persistent defect. The role of steroids in 
these cases is unclear; however, long-term follow-up is 
advisable. 
The pathogenesis of TPE may be, in some aspects, 
analogous to atopic asthma, as both share an obstructive 
ventilatory picture, partially reversible with P-agonists, and 
high serum levels of the IgE antibody class. All house dust 
mite Dermatophagoides ptevonyssinus-specific T cell clones 
isolated from atopic asthmatic subjects produced the 
cytokine IL-4 (14). IL-4 is a product of the type 2 subset of 
T-cells whose differentiation is prominent during helminthic 
infections and allergic reactions. The cytokine is an import- 
ant stimulus for the development of both human and 
animal IgE, and allergy-related IgG4 subclass responses 
(15,16). Expression of another type 2 T-cell subset cytokine, 
IL-5, is also increased in airways of asthmatics, and leads to 
eosinophil recruitment and differentiation (17). The import- 
ance of cytokines such as IL-4 and IL-5 in regulating 
pulmonary IgE and eosinophil sequestration in TPE is not 
known, although a response similar to that in asthma may 
determine the excessive production of IgE and the local and 
systemic allergic manifestations. The limited data suggests 
that peripheral blood T-cells from patients with TPE make 
more IL-4 and IL-5 when stimulated by parasite antigen 
than do cells from other filaria-affected individuals. In 
addition, patients with TPE have higher frequencies of type 
%-like cells in general, as assessed by the analysis of T-cell 
clones derived from these patients (Tom Nutman, pers. 
comm.). It remains unclear whether these type-2-derived 
responses, including IgE, eosinophilia and mastocytosis are 
important in the protective immune response to this filarial 
parasite or are responsible for immune-mediated pathology 
or both. Studies in mice have shown that the different stages 
of B. malayi evoke different cytokine and antibody isotype 
responses (18)). 
The alveolitis causing the restrictive defect in TPE may 
have a different mechanism. This may become chronic and 
progress to fibrosis despite apparently adequate treatment. 
Diethylcarbamazine and ivermectin are both rapidly lethal 
to microfilariae, but not adult worms. It is possible that 
microfilaricidal treatment, whilst removing the antigen 
responsible for the acute type 2 response, may enable a shift 
in immune function favouring a type 1 response, and 
interferon-gamma (IFN-y) production. It is known in 
mycobacterial models that an excess of IFN-1/ may lead to 
increases in the macrophage cytokine, platelet-derived 
growth factor B (PDGF-B), which has been implicated in 
the development of the early fibrotic lesions seen in tuber- 
culosis (19). IgE itself is capable of activating macrophages 
in a leishmania model, by ligation of the low-affinity IgE 
receptor FceRl l/CD23 with the generation of nitric oxide, 
sufficient to induce antimicrobial activity in human macro- 
phages (20). It is possible that, in come cases, microfilari- 
tidal treatment, whilst removing the antigen responsible for 
the acute type 2 response, may enable a shift in immune 
function favouring a mixed type l/type 2 response, resulting 
in tissue damage and fibrosis. This mechanism is thought 
to underlay the host immunopathological response to other 
infectious diseases which may progress to tissue fibrosis, 
such as tuberculosis (21) and schistosomiasis (22,23). Work 
with cytokine knockout mice may provide answers to the 
role of both type 1 and type 2 cytokines in the protective 
immune responses and immunopathology seen in TPE. 
Egwang et al (24) have developed a mouse model that 
exhibits various features of TPE, but details on cytokine 
responses were never published. 
There is limited evidence to suggest an underlying genetic 
basis for TPE (7). It is not an obvious defect in the IgE 
control system in that IFN-y can readily switch off IgE 
synthesis from patients with TPE. Moreover, patients with 
TPE do not, characteristically, become asthmatic or suffer 
other allergies after treatment. Perhaps TPE represents the 
outcome in a few individuals in which microfilariae fail to 
downregulate the IgE response to these parasites, by induc- 
ing aberrant IL-4 by T-helper cells at the site of disease or 
possibly because of IL-4 promoter polymorphism (25). 
It is possible that advances in the understanding of the 
immune response to this parasitic organism, for which a 
convenient animal model exists to study the nature of 
nematode allergens, may provide numerous insights not 
just into the workings of the mammalian immune system, 
but might also guide research into allergic alveolitis and 
asthma. 
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